Literature DB >> 12644919

Renal tubular dysfunction in alpha-thalassemia.

Achra Sumboonnanonda1, Prida Malasit, Voravarn S Tanphaichitr, Sompong Ong-ajyooth, Siripan Petrarat, Arun Vongjirad.   

Abstract

Shortened red cell life span and excess iron cause functional and physiological abnormalities in various organ systems in thalassemia patients. In an earlier study, we showed that beta-thalassemia patients have a high prevalence of renal tubular abnormalities. The severity correlated with the degree of anemia, being least severe in patients on hypertransfusion and iron chelation therapy, suggesting that the damage might be caused by the anemia and increased oxidation induced by excess iron deposits. This study was designed to define the renal abnormalities associated with alpha-thalassemia and to correlate the renal findings with clinical parameters. Thirty-four pediatric patients (mean age 8.2+/-2.8 years) with Hb H disease or Hb H/Hb CS were studied. Ten patients (group 1) were splenectomized, with a mean duration post splenectomy of 3.5+/-1.4 years; 24 patients (group 2) had intact spleens. The results were compared with 15 normal children. Significantly higher levels of urine N-acetyl-beta- d-glycosaminidase, malondialdehyde (MDA), and beta(2)-microglobulin were found in both groups compared with normal children. An elevated urine protein/creatinine ratio was recorded in 60% of group 1 and 29% of group 2. Two patients (5.9%), 1 in each group, had generalized aminoaciduria. We found proximal tubular abnormalities in alpha-thalassemia patients. Increased oxidative stress, possibly iron induced, may play an important role, since urine MDA levels were significantly increased in both groups of patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644919     DOI: 10.1007/s00467-003-1067-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  Renal function in pediatric patients with beta-thalassemia major.

Authors:  B Aldudak; A Karabay Bayazit; A Noyan; A Ozel; A Anarat; I Sasmaz; Y Kilinç; E Gali; R Anarat; N Dikmen
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

Review 2.  Markers of tubular dysfunction.

Authors:  M Piscator
Journal:  Toxicol Lett       Date:  1989-03       Impact factor: 4.372

3.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

4.  Differences between two types of Hb H disease, alpha-thalassemia 1/alpha-thalassemia 2 and alpha-thalassemia 1/Hb constant spring.

Authors:  S Fucharoen; P Winichagoon; P Pootrakul; A Piankijagum; P Wasi
Journal:  Birth Defects Orig Artic Ser       Date:  1987

5.  Beta 2-microglobulin in urine and serum determined by ELISA technique.

Authors:  L Hemmingsen; P Skaarup
Journal:  Scand J Clin Lab Invest       Date:  1985-06       Impact factor: 1.713

Review 6.  Urinary enzymes, nephrotoxicity and renal disease.

Authors:  R G Price
Journal:  Toxicology       Date:  1982       Impact factor: 4.221

7.  Hydroxyl radical mediation of immune renal injury by desferrioxamine.

Authors:  N W Boyce; S R Holdsworth
Journal:  Kidney Int       Date:  1986-12       Impact factor: 10.612

Review 8.  Auto-oxidation and a membrane-associated 'Fenton reagent': a possible explanation for development of membrane lesions in sickle erythrocytes.

Authors:  R P Hebbel
Journal:  Clin Haematol       Date:  1985-02

9.  A simple automated colorimetric method for determination of N-acetyl- beta-D-glucosaminidase.

Authors:  J C Moore; J E Morris
Journal:  Ann Clin Biochem       Date:  1982-05       Impact factor: 2.057

Review 10.  Low molecular weight proteins in children with renal disease.

Authors:  P A Tomlinson
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

View more
  9 in total

Review 1.  Hydrops fetalis caused by homozygous alpha-thalassemia and Rh antigen alloimmunization: report of a survivor and literature review.

Authors:  Divya-Devi Joshi; H James Nickerson; Michael J McManus
Journal:  Clin Med Res       Date:  2004-11

2.  GFR in Patients with β-Thalassemia Major.

Authors:  Gai Milo; Revital Feige Gross Nevo; Idit Pazgal; Anat Gafter-Gvili; Ofer Shpilberg; Uzi Gafter; Arie Erman; Pinhas Stark
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-11       Impact factor: 8.237

3.  Renal dysfunction in patients with thalassaemia.

Authors:  Charles T Quinn; Valerie L Johnson; Hae-Young Kim; Felicia Trachtenberg; Maria G Vogiatzi; Janet L Kwiatkowski; Ellis J Neufeld; Ellen Fung; Nancy Oliveri; Melanie Kirby; Patricia J Giardina
Journal:  Br J Haematol       Date:  2011-02-21       Impact factor: 6.998

4.  Early markers of renal dysfunction in patients with beta-thalassemia major.

Authors:  Masoumeh Mohkam; Bibi Shahin Shamsian; Atoosa Gharib; Shahin Nariman; Mohammad T Arzanian
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

5.  Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study.

Authors:  Enas A Hamed; Nagla T ElMelegy
Journal:  Ital J Pediatr       Date:  2010-05-25       Impact factor: 2.638

6.  Renal function in children with beta-thalassemia major and thalassemia intermedia.

Authors:  Vladislav Smolkin; Raphael Halevy; Carina Levin; Miguel Mines; Waheeb Sakran; Katzap Ilia; Ariel Koren
Journal:  Pediatr Nephrol       Date:  2008-06-25       Impact factor: 3.714

Review 7.  Iron therapy for renal anemia: how much needed, how much harmful?

Authors:  Walter H Hörl
Journal:  Pediatr Nephrol       Date:  2007-01-06       Impact factor: 3.714

Review 8.  β-Thalassemia Intermedia: A Bird's-Eye View.

Authors:  Anthony Haddad; Paul Tyan; Amr Radwan; Naji Mallat; Ali Taher
Journal:  Turk J Haematol       Date:  2014-03-05       Impact factor: 1.831

Review 9.  Novel approach to reactive oxygen species in nontransfusion-dependent thalassemia.

Authors:  Paul I Tyan; Amr H Radwan; Assaad Eid; Anthony G Haddad; David Wehbe; Ali T Taher
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.